干血斑用于耳聋综合基因检测的可行性研究
本研究评估干血斑(DBS)作为DNA来源进行耳聋综合基因检测的可行性。对4份新鲜或存档DBS样本进行已知耳聋基因二代测序,并与全血DNA比较。结果显示DBS来源DNA质量和量满足临床检测要求,阳性对照检出致病变异,未知样本检出OTOA基因纯合缺失,表明该方案可行。
要点
- 干血斑来源DNA质量与量满足耳聋综合基因检测的临床要求
- 新鲜和存档干血斑均可用于耳聋基因二代测序
- 未知样本通过干血斑检测检出OTOA基因纯合缺失致聋原因
核心结论
- 新鲜和/或存档干血斑可用于耳聋综合基因检测,本研究为初步可行性验证。
研究设计与样本
- 初步研究,比较新鲜和存档干血斑来源DNA与全血DNA,对4份干血斑样本进行所有已知耳聋基因的二二代测序。
主要发现
- 2份阳性对照样本中检出致病变异,阴性对照未检出致病变异。
- 未知样本中检出OTOA基因纯合缺失作为耳聋病因。
- 干血斑来源DNA的数量和质量满足临床检测要求。
临床怎么用
- 新生儿采血困难时,可考虑用常规采集的干血斑替代全血进行耳聋综合基因检测。
局限性
- 本研究为初步小样本研究,仅纳入4份干血斑样本,尚需更大规模验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Comprehensive genetic testing has become integral in the evaluation of children with deafness, but the amount of blood required to obtain DNA can be prohibitive in newborns. Dried blood spots (DBSs) are routinely collected and would provide an alternative source of DNA. Our objective was to evaluate the use of DBSs for comprehensive genetic testing for deafness. DNA derived from fresh and archived DBS samples was compared with DNA from whole blood. We performed next-generation sequencing of all known deafness genes in 4 DBS samples: 2 positive controls, an unknown sample, and a negative control. The DBS-derived DNA was of sufficient quantity and quality for clinical testing. In the 2 positive control samples, pathogenic variants were identified; in the negative control, no pathogenic variants were found; and in the unknown sample, homozygous deletion of the OTOA gene was identified as the cause of deafness. This pilot study shows that comprehensive genetic testing for deafness is feasible with fresh and/or archived DBSs.
引用
- Shearer AE, Frees K, Kolbe DL, et al. Comprehensive Genetic Testing for Deafness from Fresh and Archived Dried Blood Spots. Otolaryngol Head Neck Surg. 2018. PMID: 30149782. doi:10.1177/0194599818797291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。